CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-04-01 | FRIEDMANN NADAV COO | Sale | −15,000 | $6.17 | $93K | 287,195 |
| 2010-04-01 | BARBIER REMI CEO and Chairman of the Board | Sale | −12,000 | $6.16 | $74K | 6,259,447 |
| 2010-03-16 | SCHOENHARD GRANT Chief Scientific Officer | Purchase | +10,000 | $4.40 | $44K | 58,187 |
| 2010-03-16 | SCHOENHARD GRANT Chief Scientific Officer | Purchase | +25,000 | $5.25 | $131K | 83,187 |
| 2010-03-16 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −35,000 | $6.13 | $214K | 48,187 |
| 2010-03-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | −25,000 | $5.25 | $131K | 720,000 |
| 2010-03-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | −10,000 | $4.40 | $44K | 710,000 |
| 2010-03-11 | O DONNELL MICHAEL J Director | Sale | −25,000 | $6.14 | $154K | 5,775 |
| 2010-03-03 | BARBIER REMI CEO and Chair of Board | Sale | −5,443 | $6.13 | $33K | 6,271,447 |
| 2010-03-02 | BARBIER REMI CEO and Chair of the Board | Sale | −14,667 | $6.13 | $90K | 6,276,890 |
| 2010-03-01 | BARBIER REMI CEO and Chair of the Board | Sale | −29,890 | $6.05 | $181K | 6,291,557 |
| 2010-02-25 | O DONNELL MICHAEL J Director | Option exercise | +25,000 | $2.00 | $50K | 30,775 |
| 2010-02-25 | O DONNELL MICHAEL J Director | Option exercise · Common Stock | −25,000 | $2.00 | $50K | 225,000 |
| 2010-02-02 | BARBIER REMI CEO and Chair of the Board | Gift | −28,800 | 6,321,447 | ||
| 2010-02-02 | BARBIER REMI CEO and Chair of the Board | Gift | +9,600 | 48,375 | ||
| 2010-02-02 | BARBIER REMI CEO, President, Chairman of Bd | Sale | −20,200 | $5.34 | $108K | 6,350,247 |
| 2010-02-01 | BARBIER REMI CEO, President, Chairman of Bd | Sale | −29,800 | $5.30 | $158K | 6,370,447 |
| 2010-01-19 | FRIEDMANN NADAV Chief Medical Officer | Other acquisition | +14,937 | 302,195 |
Page 25 of 25 · 498 trades